Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Patients With Long Coronary Artery Disease | Zendy

YoungHak Kim | Zendy; SeongWook Park | Zendy; SeungWhan Lee | Zendy; DukWoo Park | Zendy; SungCheol Yun | Zendy; Cheol Whan Lee | Zendy; MyeongKi Hong | Zendy; HyunSook Kim | Zendy; JaeKi Ko | Zendy; JaeHyeong Park | Zendy; JaeHwan Lee | Zendy; Si Wan Choi | Zendy; In Whan Seong | Zendy; Yoon Haeng Cho | Zendy; Nae-Hee Lee | Zendy; June Hong Kim | Zendy; Kook-Jin Chun | Zendy; SeungJung Park | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Patients With Long Coronary Artery Disease

Author(s) -

YoungHak Kim,

SeongWook Park,

SeungWhan Lee,

DukWoo Park,

SungCheol Yun,

Cheol Whan Lee,

MyeongKi Hong,

HyunSook Kim,

JaeKi Ko,

JaeHyeong Park,

JaeHwan Lee,

Si Wan Choi,

In Whan Seong,

Yoon Haeng Cho,

Nae-Hee Lee,

June Hong Kim,

Kook-Jin Chun,

SeungJung Park

Publication year - 2006

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.106.666396

Subject(s) - medicine , restenosis , stent , cardiology , myocardial infarction , sirolimus , coronary artery disease , lesion , clinical endpoint , paclitaxel , drug eluting stent , randomized controlled trial , surgery , chemotherapy

Outcomes remain relatively unfavorable for stent-based coronary intervention of lesions with long diseased segments. This study compared sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) for long coronary lesions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research